Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Equity (Parenthetical)

v3.22.4
Consolidated Statements of Equity (Parenthetical) - shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Stockholders' Equity [Abstract]      
Common Shares of beneficial interest, shares outstanding (in shares) 112,423,893 112,327,533 112,181,759
Conversion of common units to common shares (in shares) 0 8,054 14,009
Share-based compensation issuance, net of redemptions (in shares) 96,360 137,720 99,045